Neuren Pharmaceuticals Limited (NURPF)

Neuren Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 11, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,223	983	2,166	681	345	114
Market Cap Growth	7.17%	-54.64%	218.26%	97.12%	203.91%	-34.90%
Enterprise Value	1,010	851	2,108	660	332	107
Last Close Price	9.86	7.57	16.98	5.45	2.79	0.96
PE Ratio	12.52	11.18	20.23	5442.54	-	-
PS Ratio	8.52	7.32	13.70	64.96	148.54	205.40
PB Ratio	5.77	4.36	15.49	24.08	12.10	6.09
P/TBV Ratio	5.77	4.36	15.49	24.08	12.10	6.09
P/FCF Ratio	13.56	-	17.19	279.73	-	-
P/OCF Ratio	13.56	-	17.18	278.25	-	-
EV/Sales Ratio	6.48	6.34	13.33	62.94	142.84	192.61
EV/EBITDA Ratio	7.71	7.67	15.52	-	-	-
EV/EBIT Ratio	7.71	7.67	15.52	-	-	-
EV/FCF Ratio	11.20	-	16.73	271.04	-	-
Asset Turnover	0.78	0.66	1.59	0.37	0.10	0.04
Quick Ratio	40.42	8.69	5.68	24.59	47.58	33.13
Current Ratio	40.42	8.73	5.78	25.77	49.87	33.13
Return on Equity (ROE)	54.96%	49.92%	127.30%	0.46%	-24.57%	-48.32%
Return on Assets (ROA)	41.13%	34.05%	85.52%	-1.10%	-15.83%	-27.98%
Return on Invested Capital (ROIC)	605.76%	235.12%	-	-37.74%	-663.42%	-117453.33%
Return on Capital Employed (ROCE)	56.90%	49.20%	97.10%	-1.80%	-21.00%	-36.40%
Earnings Yield	7.99%	8.95%	4.94%	0.02%	-1.64%	-6.24%
FCF Yield	7.37%	-0.71%	5.82%	0.36%	-2.10%	-5.49%
Buyback Yield / Dilution	0.98%	-0.01%	-1.44%	-8.76%	-10.71%	-6.88%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.